Home » Topics » Regulatory

Regulatory
RSS

Roche's MabThera and Xeloda cleared for new indications in Europe

March 26, 2002

Remicade granted priority review as Crohn's disease monotherapy

March 25, 2002

Label change for Xenical cleared by CPMP

March 25, 2002

FDA approval for Avinza for once-daily treatment of chronic pain

March 22, 2002

Health Canada approves expanded label for ProstaScint

March 20, 2002

FDA approval for new formulation of Visicol

March 18, 2002

Risperdal approved for delaying schizophrenia relapse in U.S.

March 15, 2002

Extended-release Zerit has similar virological activity to immediate-release drug

March 15, 2002

CPMP recommends approval of irbesartan in diabetic renal disease

March 13, 2002

CPMP recommends approval of Avonex in early-stage MS

March 11, 2002